Abstract

The purpose of this study was to evaluate a planning strategy based on Acuros with density override in comparison with AAA without and with the override. Ten lung-tumor patients were selected with each PTV size around 2 - 4 cm and were imaged using slow scan, followed by four-dimensional (4D) imaging limited to the target. On each phase-specific image, gross tumor volume (GTV) was contoured. Summed over all phases, an integrated GTV (iGTV) was generated and copied to the slow scan. A treatment plan was created using a dynamic-conformal-arc technique with AAA to prescribe 60 Gy to 95% of PTV (iGTV + 0.5 cm). Each AAA-based plan was regenerated by overriding the density of the setup margin of PTV by GTV density (modeling tumor-position uncertainty). It was also regenerated with Acuros and the override. The three plans were validated in 4D dose to PTV, after similarly overriding PTV density (phase-specific), accurately calculating with Acuros, and summing the phase-specific plans through organ/dose registration. The Acuros-based plan with the override, the AAA-based plan, and the AAA-based plan with the override provided 4D PTV doses of 63.9, 67.9, and 62 Gy at D95%, respectively, averaged over all patients. The override with Acuros and AAA produced lesser 4D doses, closer to the associated 3D doses, respectively, than that without the override, with better conformity and inhomogeneity. With the override in common, Acuros provided a greater dose to PTV than that by AAA. The Acuros with the override, which was more accurate than the AAA without the override, is clinically recommended.

Highlights

  • Stereotactic-body-radiation therapy (SBRT) has been widely used for the treatment of relatively small lung tumors [1]

  • We have comparatively evaluated the proposed plan with the classic analytic anisotropic algorithm (AAA)-based plan without the override in terms of four-dimensional (4D [15]) doses planned in gross tumor volume (GTV) and its planning target volume (PTV) (PTV_4D) as well as the three-dimensional (3D) doses in integrated GTV (iGTV) and PTV, while the 4D doses can serve as benchmarks for the 3D doses

  • Ten patients who had been treated with SBRT to their lungs using dynamic conformal arc (DCA) between 2013 and 2016 were selected based on the following criteria: 1) tumors were separated from the chest wall or mediastinum by greater than 1.5 cm; 2) tumor sizes were between 2 - 4 cm in either their lateral or longitudinal dimensions; and 3) treatment plans had been generated using 6 MV X-rays and AAA for a total dose of 60 Gy in 5 fractions, prescribed to 95% volume of PTV

Read more

Summary

Introduction

Stereotactic-body-radiation therapy (SBRT) has been widely used for the treatment of relatively small lung tumors [1]. SBRT is intended to optimize tumor control while maximally sparing normal tissues such as the lung To achieve this goal, it is delivered in a small number of treatment fractions by providing a highly conformal dose around the tumors [2]. Due to the sharp density change in the interface and the insufficient distance of dose buildup and lateral radiation transport in the tumors, this condition challenges accurate dose calculation in the tumors and interface areas. This challenge is further complicated as the setup margin of the tumors is occupied by the lung that cannot represent them in terms of a similar physical density

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.